AACR Cancer Progress Report 2019: Harnessing Research Discoveries for Patient Benefit
Today, the American Association for Cancer Research (AACR) released its ninth annual Cancer Progress Report. The report highlights how...
Today, the American Association for Cancer Research (AACR) released its ninth annual Cancer Progress Report. The report highlights how...
For the third year running, the American Association for Cancer Research (AACR) has been selected as the beneficiary of...
Clinical trials are an essential part of cancer research. They ensure that scientific discoveries are translated into advances in...
Conference co-chair Elaine R. Mardis, PhD, discusses the third conference in the AACR's Precision Medicine Series, “Integrating Clinical Genomics...
In less than a month, the AACR Annual Meeting 2018 will kick off in Chicago, Illinois. The meeting is...
Beginning this Friday, Philadelphia will host the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. The conference,...
The FDA has approved nivolumab for treating patients with recurrent or metastatic squamous cell carcinoma of the head...
When Michael Lawing was diagnosed with stage 3 renal cell carcinoma in 1997, he knew almost nothing about the...
Immunotherapy is revolutionizing the treatment of cancer. As discussed in an earlier post on this blog, immunotherapeutics that work...
Much has been written, including on this blog, about the rapidly expanding use of immunotherapy to treat an increasing...
The human microbiome – the collection of bacteria, viruses, fungi, and other microorganisms that live inside and on the...
As the temperature soared this summer, the laps around the park became harder to endure. When her skin chafed...
Every September 24, World Cancer Research Day provides an opportunity to raise awareness about the important role research plays...
The San Antonio Breast Cancer Symposium (SABCS), which marks its 40th anniversary this year, has become the world's premier...
A highly complex filtering system, the kidneys process roughly half a cup of blood every minute, isolating waste and...
Today, the American Association for Cancer Research (AACR) released its seventh annual Cancer Progress Report. The report highlights how...
After three decades of failed efforts to target the elusive KRAS and its family members NRAS and HRAS, proto-oncogenes...
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....
Women have played many pivotal roles at the American Association for Cancer Research (AACR), from the organization’s earliest years...
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
On Sunday, almost 300 of the greatest minds in ovarian cancer research will come together in Pittsburgh to discuss...
On September 6, 2018, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research hosted...
A study that examined the catchment areas of 102 cancer centers in the U.S. found that while over a...
“These are extraordinary times,” began Hugh Auchincloss, MD, as he opened up the recent NIH-AACR Cancer, Autoimmunity, and Immunology...
As we spring into a new month, it is once again time for our monthly staple of Editors’ Picks. For...
On June 1, the U.S. Food and Drug Administration (FDA) approved a liquid biopsy test, a companion diagnostic test...
Policymakers, parents, teachers, and public health professionals have all expressed concern about the rise in teen vaping and a...
“Are you ready to have a great meeting?” Robert Vonderheide, MD, DPhil, asked the nearly 11,000 attendees gathered in...
Guest Post by Graham A. Colditz, MD, DrPH Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School...